These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

381 related items for PubMed ID: 24946270

  • 1. Combinatorial anticancer effects of curcumin and 5-fluorouracil loaded thiolated chitosan nanoparticles towards colon cancer treatment.
    Anitha A, Deepa N, Chennazhi KP, Lakshmanan VK, Jayakumar R.
    Biochim Biophys Acta; 2014 Sep; 1840(9):2730-43. PubMed ID: 24946270
    [Abstract] [Full Text] [Related]

  • 2. In vitro combinatorial anticancer effects of 5-fluorouracil and curcumin loaded N,O-carboxymethyl chitosan nanoparticles toward colon cancer and in vivo pharmacokinetic studies.
    Anitha A, Sreeranganathan M, Chennazhi KP, Lakshmanan VK, Jayakumar R.
    Eur J Pharm Biopharm; 2014 Sep; 88(1):238-51. PubMed ID: 24815764
    [Abstract] [Full Text] [Related]

  • 3. An oral drug delivery system with programmed drug release and imaging properties for orthotopic colon cancer therapy.
    Song Q, Jia J, Niu X, Zheng C, Zhao H, Sun L, Zhang H, Wang L, Zhang Z, Zhang Y.
    Nanoscale; 2019 Aug 29; 11(34):15958-15970. PubMed ID: 31418432
    [Abstract] [Full Text] [Related]

  • 4. 5-Fluorouracil-loaded poly(ε-caprolactone) nanoparticles combined with phage E gene therapy as a new strategy against colon cancer.
    Ortiz R, Prados J, Melguizo C, Arias JL, Ruiz MA, Alvarez PJ, Caba O, Luque R, Segura A, Aránega A.
    Int J Nanomedicine; 2012 Aug 29; 7():95-107. PubMed ID: 22275826
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetic and anti-colon cancer properties of curcumin-containing chitosan-pectinate composite nanoparticles.
    Alkhader E, Roberts CJ, Rosli R, Yuen KH, Seow EK, Lee YZ, Billa N.
    J Biomater Sci Polym Ed; 2018 Dec 29; 29(18):2281-2298. PubMed ID: 30376409
    [Abstract] [Full Text] [Related]

  • 6. PHBV/PLGA nanoparticles for enhanced delivery of 5-fluorouracil as promising treatment of colon cancer.
    Handali S, Moghimipour E, Rezaei M, Ramezani Z, Dorkoosh FA.
    Pharm Dev Technol; 2020 Feb 29; 25(2):206-218. PubMed ID: 31648589
    [Abstract] [Full Text] [Related]

  • 7. Enhancing therapeutic efficacy: sustained delivery of 5-fluorouracil (5-FU) via thiolated chitosan nanoparticles targeting CD44 in triple-negative breast cancer.
    Anjum S, Naseer F, Ahmad T, Jahan F, Qadir H, Gul R, Kousar K, Sarwar A, Shabbir A.
    Sci Rep; 2024 May 19; 14(1):11431. PubMed ID: 38763930
    [Abstract] [Full Text] [Related]

  • 8. Formulation of Quaternized Aminated Chitosan Nanoparticles for Efficient Encapsulation and Slow Release of Curcumin.
    Omer AM, Ziora ZM, Tamer TM, Khalifa RE, Hassan MA, Mohy-Eldin MS, Blaskovich MAT.
    Molecules; 2021 Jan 16; 26(2):. PubMed ID: 33467056
    [Abstract] [Full Text] [Related]

  • 9. Preparation of anti-tumor nanoparticle and its inhibition to peritoneal dissemination of colon cancer.
    Tang Q, Wang Y, Huang R, You Q, Wang G, Chen Y, Jiang Z, Liu Z, Yu L, Muhammad S, Wang X.
    PLoS One; 2014 Jan 16; 9(6):e98455. PubMed ID: 24896096
    [Abstract] [Full Text] [Related]

  • 10. Synthesis of galactosylated chitosan/5-fluorouracil nanoparticles and its characteristics, in vitro and in vivo release studies.
    Cheng M, Han J, Li Q, He B, Zha B, Wu J, Zhou R, Ye T, Wang W, Xu H, Hou Y.
    J Biomed Mater Res B Appl Biomater; 2012 Nov 16; 100(8):2035-43. PubMed ID: 22865703
    [Abstract] [Full Text] [Related]

  • 11. Preparation and characterization of polymeric nanoparticles surface modified with chitosan for target treatment of colorectal cancer.
    Badran MM, Mady MM, Ghannam MM, Shakeel F.
    Int J Biol Macromol; 2017 Feb 16; 95():643-649. PubMed ID: 27908720
    [Abstract] [Full Text] [Related]

  • 12. Mucoadhesive chitosan and thiolated chitosan nanoparticles containing alpha mangostin for possible Colon-targeted delivery.
    Samprasit W, Opanasopit P, Chamsai B.
    Pharm Dev Technol; 2021 Mar 16; 26(3):362-372. PubMed ID: 33423571
    [Abstract] [Full Text] [Related]

  • 13. Stealth recombinant human serum albumin nanoparticles conjugating 5-fluorouracil augmented drug delivery and cytotoxicity in human colon cancer, HT-29 cells.
    Sharma A, Kaur A, Jain UK, Chandra R, Madan J.
    Colloids Surf B Biointerfaces; 2017 Jul 01; 155():200-208. PubMed ID: 28431329
    [Abstract] [Full Text] [Related]

  • 14. Curcumin-polymeric nanoparticles against colon-26 tumor-bearing mice: cytotoxicity, pharmacokinetic and anticancer efficacy studies.
    Chaurasia S, Chaubey P, Patel RR, Kumar N, Mishra B.
    Drug Dev Ind Pharm; 2016 Jul 01; 42(5):694-700. PubMed ID: 26165247
    [Abstract] [Full Text] [Related]

  • 15. Preparation and characterization of novel chitosan-protamine nanoparticles for nucleus-targeted anticancer drug delivery.
    Yu X, Hou J, Shi Y, Su C, Zhao L.
    Int J Nanomedicine; 2016 Jul 01; 11():6035-6046. PubMed ID: 27881917
    [Abstract] [Full Text] [Related]

  • 16. Folic acid-decorated and PEGylated PLGA nanoparticles for improving the antitumour activity of 5-fluorouracil.
    El-Hammadi MM, Delgado ÁV, Melguizo C, Prados JC, Arias JL.
    Int J Pharm; 2017 Jan 10; 516(1-2):61-70. PubMed ID: 27825867
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetic characteristics and anticancer effects of 5-fluorouracil loaded nanoparticles.
    Li S, Wang A, Jiang W, Guan Z.
    BMC Cancer; 2008 Apr 15; 8():103. PubMed ID: 18412945
    [Abstract] [Full Text] [Related]

  • 18. In vitro additive antitumor effects of dimethoxycurcumin and 5-fluorouracil in colon cancer cells.
    Zhao H, Liu Q, Wang S, Dai F, Cheng X, Cheng X, Chen W, Zhang M, Chen D.
    Cancer Med; 2017 Jul 15; 6(7):1698-1706. PubMed ID: 28573788
    [Abstract] [Full Text] [Related]

  • 19. Cytocompatible chitosan-graft-mPEG-based 5-fluorouracil-loaded polymeric nanoparticles for tumor-targeted drug delivery.
    Antoniraj MG, Ayyavu M, Henry LJK, Nageshwar Rao G, Natesan S, Sundar DS, Kandasamy R.
    Drug Dev Ind Pharm; 2018 Mar 15; 44(3):365-376. PubMed ID: 28835136
    [Abstract] [Full Text] [Related]

  • 20. In vitro cytotoxicity and in vivo efficacy of 5-fluorouracil-loaded enteric-coated PEG-cross-linked chitosan microspheres in colorectal cancer therapy in rats.
    Ganguly K, Kulkarni AR, Aminabhavi TM.
    Drug Deliv; 2016 Oct 15; 23(8):2838-2851. PubMed ID: 26530807
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.